Firmware-Only Upgrade Paves Way for dorsaVi’s Neuromorphic Sensor Revolution

A New Era for Wearable Sensor Intelligence

dorsaVi Limited, an Australian leader in wearable sensor technology, has announced the development of Sensor V6.5, a significant firmware upgrade that marks the first introduction of on-sensor intelligence to its FDA- and TGA-cleared wearable platform. This upgrade represents a strategic leap towards embedding computation directly within the sensor hardware, reducing reliance on external devices and cloud processing.

Traditionally, dorsaVi’s sensors have captured high-fidelity movement data, with analytics performed on edge devices or cloud platforms. While effective, this architecture introduces latency and dependency on connectivity. Sensor V6.5 changes this by enabling selected analytics and signal interpretation to occur within the sensor itself, improving responsiveness for clinical, workplace, and elite sporting applications.

Firmware Upgrade Without Hardware Replacement

One of the most compelling aspects of the V6.5 upgrade is its delivery as a firmware update to existing hardware. This means dorsaVi’s current clients, including the Select Medical Physical Therapy network in the US, Dr. Patel’s elite sport program, and the SEROMA European clinical study, can immediately benefit from enhanced on-sensor processing without needing to replace their devices. This approach offers a near-term commercial advantage by accelerating access to improved capabilities.

The upgrade expands the computational capacity within the existing sensor, enabling more sophisticated real-time analysis and laying the architectural foundation for future integration of neuromorphic computing and resistive RAM (RRAM) technologies. These advancements are part of dorsaVi’s broader Ultra Edge Intelligence strategy, which aims to bring AI-driven decision-making to the point of data capture.

Strategic Alignment with Regulatory Trends and Robotics

Sensor V6.5’s neuromorphic-ready architecture aligns closely with emerging European regulatory frameworks, such as the EU AI Act, which increasingly demand validated, on-device AI processing for medical and autonomous systems. dorsaVi’s participation in multi-site European clinical research through the SEROMA study positions the company well within this evolving regulatory landscape.

Beyond healthcare, dorsaVi is exploring the potential for its sensor platform to serve as a proprioceptive input layer for collaborative robots (cobots). These robots require real-time, clinically validated human movement data to safely interact with people. The V6.5 upgrade’s low-latency, on-sensor processing capabilities could offer a unique advantage in this space, although this remains an exploratory direction rather than a committed product roadmap.

Looking Ahead: From Firmware to Next-Gen Hardware

While V6.5 is a significant milestone, it is a stepping stone toward dorsaVi’s vision of Ultra-Edge Platform 1.0, which will integrate native RRAM and full neuromorphic compute capabilities in new hardware generations. Collaborations with research institutions like ITRI and NTU aim to deliver ultra-low-power, always-on sensors capable of sub-millisecond, reflex-speed analytics.

CEO Mat Regan emphasised the deliberate sequencing of this technology roadmap: delivering immediate client value through firmware upgrades today while preparing the platform for transformative hardware innovations tomorrow. This approach balances commercial pragmatism with long-term technological ambition.